Early P&R / Market Access Support

Assess commercialisation issues for preclinical and Phase I products to inform developing strategy.

Initial Price Assessments / due diligence for early-stage products, informing licensing, forecasting and resource allocation decisions .

Example:
ABPPC advised EU client on issues associated with developing candidate molecule for number of different neurology indications (Epilepsy, Multiple Sclerosis and Parkinson’s Disease) to help determine commercial potential and issues associated with bringing the product to the market in each application